Skip to main content
Erschienen in: Inflammation 3/2018

19.02.2018 | ORIGINAL ARTICLE

Periodontitis May Restrain the Mandibular Bone Healing via Disturbing Osteogenic and Osteoclastic Balance

verfasst von: Rongjing Zhou, Lili Shen, Chengzhe Yang, Limei Wang, Hongmei Guo, Pishan Yang, Aimei Song

Erschienen in: Inflammation | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Periodontitis has been advocated as a systematic chronic low-grade infection burden. However, the relationship between periodontitis and bone defect healing has not been elucidated. One hundred and eight male Wister rats were randomly assigned into three groups: control (healthy) group, periodontitis group, and periodontitis plus human tumor necrosis factor receptorII:IgG Fc fusion protein (rhTNFR:Fc) group. The experimental periodontitis model was established by ligaturing with orthodontic wire and silk suture plus local administration of 20 μl of lipopolysaccharide (LPS). Mandibular bone defects in size of 4 × 2 × 1 mm were created for all the rats and rhTNFR:Fc subcutaneously injected at neck at a dose of 2.5 mg/kg every 3 days for the periodontitis plus rhTNFR:Fc group. The gene and protein expressions of bone-related markers in the healing tissue were monitored and new bone formation was histologically evaluated. Tartrate-resistant acid phosphatase (TRAP) staining was performed to determine the number of osteoclasts. The results showed that the mRNA and protein expressions of osteogenesis-related markers were significantly lower while nuclear factor of activated T cells, cytoplasmic 1 (NFATc1) gene expression was significantly higher in the periodontitis group. The periodontitis group showed decreased new bone formation and increased number of osteoclasts when compared to the control group. However, there was no significant difference between the periodontitis plus rhTNFR:Fc group and the control group. These results demonstrated that periodontitis may restrain the mandibular bone healing via disturbing osteogenic and osteoclastic balance in which tumor necrosis factor-α (TNF-α) could act as a leverage.
Literatur
1.
Zurück zum Zitat Duarte, P.M., J.P. Bezerra, T.S. Miranda, et al. 2014. Local levels of inflammatory mediators in uncontrolled type 2 diabetic subjects with chronic periodontitis. Journal of Clinical Periodontology 41 (1): 11–18.CrossRefPubMed Duarte, P.M., J.P. Bezerra, T.S. Miranda, et al. 2014. Local levels of inflammatory mediators in uncontrolled type 2 diabetic subjects with chronic periodontitis. Journal of Clinical Periodontology 41 (1): 11–18.CrossRefPubMed
2.
Zurück zum Zitat Michalowicz, S.B., J.S. Hodges, A.J. DiAngelis, et al. 2006. Treatment of periodontal disease and the risk of preterm birth. The New England Journal of Medicine 355 (18): 1885–1894.CrossRefPubMed Michalowicz, S.B., J.S. Hodges, A.J. DiAngelis, et al. 2006. Treatment of periodontal disease and the risk of preterm birth. The New England Journal of Medicine 355 (18): 1885–1894.CrossRefPubMed
3.
Zurück zum Zitat Genco, R.J., and T.E. Van Dyke. 2010. Prevention: reducing the risk of cvd in patients with periodontitis. Nature Reviews. Cardiology 7 (9): 479–480.PubMed Genco, R.J., and T.E. Van Dyke. 2010. Prevention: reducing the risk of cvd in patients with periodontitis. Nature Reviews. Cardiology 7 (9): 479–480.PubMed
4.
Zurück zum Zitat Forner, L., T. Larsen, M. Kilian, et al. 2006. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. Journal of Clinical Periodontology 33 (6): 401–407.CrossRefPubMed Forner, L., T. Larsen, M. Kilian, et al. 2006. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. Journal of Clinical Periodontology 33 (6): 401–407.CrossRefPubMed
5.
Zurück zum Zitat Fentoğlu, O., F.Y. Kirzioğlu, M. Ozdem, et al. 2012. Proinflammatory cytokine levels in hyperlipidemic patients with periodontitis after periodontal treatment. Oral Diseases 18 (3): 299–306.CrossRefPubMed Fentoğlu, O., F.Y. Kirzioğlu, M. Ozdem, et al. 2012. Proinflammatory cytokine levels in hyperlipidemic patients with periodontitis after periodontal treatment. Oral Diseases 18 (3): 299–306.CrossRefPubMed
6.
Zurück zum Zitat Varga, J., A. Domokos, I. Barna, et al. 2011. Lack of vasopressindoes not prevent the behavioural and endocrine changes induced by chronic unpredictable stress. Brain Research Bulletin 84 (1): 45–52.CrossRefPubMed Varga, J., A. Domokos, I. Barna, et al. 2011. Lack of vasopressindoes not prevent the behavioural and endocrine changes induced by chronic unpredictable stress. Brain Research Bulletin 84 (1): 45–52.CrossRefPubMed
7.
Zurück zum Zitat Gurav, A.N. 2014. The implication of periodontitis in vascular endothelial dysfunction. European Journal of Clinical Investigation 44 (10): 1000–1009.CrossRefPubMed Gurav, A.N. 2014. The implication of periodontitis in vascular endothelial dysfunction. European Journal of Clinical Investigation 44 (10): 1000–1009.CrossRefPubMed
8.
Zurück zum Zitat Teles, F.R., R.P. Teles, L. Martin, et al. 2012. Relationships among interleukin-6, tumor necrosis factor-α, adipokines, vitamin D, and chronic periodontitis. Journal of Periodontology 83 (9): 1183–1191.CrossRefPubMed Teles, F.R., R.P. Teles, L. Martin, et al. 2012. Relationships among interleukin-6, tumor necrosis factor-α, adipokines, vitamin D, and chronic periodontitis. Journal of Periodontology 83 (9): 1183–1191.CrossRefPubMed
10.
Zurück zum Zitat Hughes, F.J., W. Turner, G. Belibasakis, et al. 2006. Effects of growth factors and cytokines on osteoblast differentiation. Periodontology 2000 (41): 48–72.CrossRef Hughes, F.J., W. Turner, G. Belibasakis, et al. 2006. Effects of growth factors and cytokines on osteoblast differentiation. Periodontology 2000 (41): 48–72.CrossRef
11.
Zurück zum Zitat Huang, H., N. Zhao, X. Xu, et al. 2011. Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells. Cell Proliferation 44 (5): 420–427.CrossRefPubMed Huang, H., N. Zhao, X. Xu, et al. 2011. Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells. Cell Proliferation 44 (5): 420–427.CrossRefPubMed
12.
Zurück zum Zitat Ye, X., H. Huang, N. Zhao, et al. 2016. Inhibition of Runx2 signaling by TNF-α in ST2 murine bone marrow stromal cells undergoing osteogenic differentiation. In Vitro Cellular & Developmental Biology - Animal 52 (10): 1026–1033.CrossRef Ye, X., H. Huang, N. Zhao, et al. 2016. Inhibition of Runx2 signaling by TNF-α in ST2 murine bone marrow stromal cells undergoing osteogenic differentiation. In Vitro Cellular & Developmental Biology - Animal 52 (10): 1026–1033.CrossRef
13.
Zurück zum Zitat Wang, L., J. Zhang, C. Wang, et al. 2017. Low concentrations of TNF-α promote osteogenic differentiation via activation of the ephrinB2-EphB4 signalling pathway. Cell Proliferation 50 (1). Wang, L., J. Zhang, C. Wang, et al. 2017. Low concentrations of TNF-α promote osteogenic differentiation via activation of the ephrinB2-EphB4 signalling pathway. Cell Proliferation 50 (1).
14.
Zurück zum Zitat Timmen, M., H. Hidding, B. Wieskötter, et al. 2014. Influence of anti TNF-alpha antibody treatment on fracture healing under chronic inflammation. BMC Musculoskeletal Disorders 15: 184.CrossRefPubMedPubMedCentral Timmen, M., H. Hidding, B. Wieskötter, et al. 2014. Influence of anti TNF-alpha antibody treatment on fracture healing under chronic inflammation. BMC Musculoskeletal Disorders 15: 184.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Claes, L., S. Recknagel, and A. Ignatius. 2012. Fracture healing under healthy and inflammatory conditions. Nature Reviews Rheumatology 8 (3): 133–143.CrossRefPubMed Claes, L., S. Recknagel, and A. Ignatius. 2012. Fracture healing under healthy and inflammatory conditions. Nature Reviews Rheumatology 8 (3): 133–143.CrossRefPubMed
17.
Zurück zum Zitat Crawford, J.M., M.A. Taubman, and D.J. Smith. 1978. The natural history of periodontal bone loss in germfree and gnotobiotic rats infected with periodontopathic microorganisms. Journal of Periodontal Research 13 (4): 316–325.CrossRefPubMed Crawford, J.M., M.A. Taubman, and D.J. Smith. 1978. The natural history of periodontal bone loss in germfree and gnotobiotic rats infected with periodontopathic microorganisms. Journal of Periodontal Research 13 (4): 316–325.CrossRefPubMed
18.
Zurück zum Zitat Liu, H., J. Cui, W. Feng, et al. 2015. Local administration of calcitriol positively influences bone remodeling and maturation during restoration of mandibular bone defects in rats. Materials Science & Engineering C - Materials for Biological Applications 49: 14–24.CrossRefPubMed Liu, H., J. Cui, W. Feng, et al. 2015. Local administration of calcitriol positively influences bone remodeling and maturation during restoration of mandibular bone defects in rats. Materials Science & Engineering C - Materials for Biological Applications 49: 14–24.CrossRefPubMed
19.
Zurück zum Zitat Loos, B.G. 2005. Systemic markers of inflammation in periodontitis. Journal of Periodontology 76: 2106–2115.CrossRefPubMed Loos, B.G. 2005. Systemic markers of inflammation in periodontitis. Journal of Periodontology 76: 2106–2115.CrossRefPubMed
20.
Zurück zum Zitat Bartold, P.M., M.D. Cantley, and D.R. Haynes. 2010. Mechanisms and control of pathologic bone loss in periodontitis. Periodontology 2000 (53): 55–69.CrossRef Bartold, P.M., M.D. Cantley, and D.R. Haynes. 2010. Mechanisms and control of pathologic bone loss in periodontitis. Periodontology 2000 (53): 55–69.CrossRef
21.
Zurück zum Zitat Goncalves, D.C., R.C. Evangelista, R.R. da Silva, et al. 2014. Infliximab attenuates inflammatory osteolysis in a model of periodontitis in Wistar rats. Experimental Biology Medicine (Maywood) 239 (4): 442–453.CrossRef Goncalves, D.C., R.C. Evangelista, R.R. da Silva, et al. 2014. Infliximab attenuates inflammatory osteolysis in a model of periodontitis in Wistar rats. Experimental Biology Medicine (Maywood) 239 (4): 442–453.CrossRef
22.
Zurück zum Zitat Di Paola, R., E. Mazzon, C. Muià, et al. 2007. Effects of etanercept, a tumor necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats. British Journal of Pharmacology 150 (3): 286–297.CrossRefPubMedPubMedCentral Di Paola, R., E. Mazzon, C. Muià, et al. 2007. Effects of etanercept, a tumor necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats. British Journal of Pharmacology 150 (3): 286–297.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Hotamisligil, G.S., N.S. Shargill, and B.M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (5091): 87–91.CrossRefPubMed Hotamisligil, G.S., N.S. Shargill, and B.M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (5091): 87–91.CrossRefPubMed
24.
Zurück zum Zitat Zhang, Y., and D. Wang. TNF-α effects on fracture healing in diet-induced obesity rats. Shanxi Medical University. Zhang, Y., and D. Wang. TNF-α effects on fracture healing in diet-induced obesity rats. Shanxi Medical University.
25.
Zurück zum Zitat Hu, D., C. Bao, S. Chen, et al. 2009. A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China. Rheumatology International 29 (3): 297–303.CrossRefPubMed Hu, D., C. Bao, S. Chen, et al. 2009. A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China. Rheumatology International 29 (3): 297–303.CrossRefPubMed
26.
Zurück zum Zitat Wang LM, Zhao N, Zhang J, et al. 2017. TNF-α inhibits osteogenic differentiation of pre-osteoblasts by down-regulation of EphB4 signaling via activated NF-кB signaling pathway. Journal of Periodontal Research Aug 31. Wang LM, Zhao N, Zhang J, et al. 2017. TNF-α inhibits osteogenic differentiation of pre-osteoblasts by down-regulation of EphB4 signaling via activated NF-кB signaling pathway. Journal of Periodontal Research Aug 31.
27.
Zurück zum Zitat Shen LL, Zhang LX, Wang LM, et al. 2016. Disturbed expression of EphB4, but not EphrinB2, inhibited bone regeneration in an in vivo inflammatory microenvironment. Mediators of Inflammation Epub 2016. Shen LL, Zhang LX, Wang LM, et al. 2016. Disturbed expression of EphB4, but not EphrinB2, inhibited bone regeneration in an in vivo inflammatory microenvironment. Mediators of Inflammation Epub 2016.
Metadaten
Titel
Periodontitis May Restrain the Mandibular Bone Healing via Disturbing Osteogenic and Osteoclastic Balance
verfasst von
Rongjing Zhou
Lili Shen
Chengzhe Yang
Limei Wang
Hongmei Guo
Pishan Yang
Aimei Song
Publikationsdatum
19.02.2018
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2018
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0751-5

Weitere Artikel der Ausgabe 3/2018

Inflammation 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.